FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Front Vet Sci / A pharmacokinetic study on red ginseng with furosemide in eq...
Frontiers in veterinary science2023; 10; 1319998; doi: 10.3389/fvets.2023.1319998

A pharmacokinetic study on red ginseng with furosemide in equine.

Abstract: Red ginseng (RG) is a popular ingredient in traditional Korean medicine that has various health benefits. It is commonly taken orally as a dietary supplement; however, its potential interactions with concomitantly administered drugs are unclear. In this study, we examined the pharmacokinetic interaction between furosemide and RG in equine plasma. Liquid chromatography with tandem mass spectrometry analysis was performed to evaluate ginsenosides in the plasma of horses after feeding them RG and furosemide and validate the results. A single bolus of furosemide (0.5 mg/kg) was administered intravenously to female horses that had consumed RG (600 mg/kg/day) every morning for 3 weeks (experimental group), and blood samples were collected from 0 to 24 h, analyzed, and compared with those from female horses that did not consume RG (control group). Four (20s)-protopanaxadiol ginsenosides (Rb1, Rb2, Rc, and Rd) were detected in the plasma. Rb1 and Rc individually showed a high concentration distribution in the plasma. The C, AUC, and AUC of furosemide was significantly increased in the experimental group ( < 0.05), while the CL, V, and V was decreased ( < 0.05,  < 0.01). These changes indicate the potential for pharmacokinetic interactions between furosemide and RG.
Copyright © 2023 Kwak, Lee, Choi, Park, Kim, Kim, Yoon and Yoo.
Get Full Text
Publication Date: 2023-11-24 PubMed ID: 38076549PubMed Central: PMC10704239DOI: 10.3389/fvets.2023.1319998Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article discusses the interaction between red ginseng and furosemide, a diuretic drug, in horses and how their combined use could potentially affect the distribution and concentration of these substances in the body.

Research Overview

The researchers intended to uncover potential interaction between red ginseng, an ingredient commonly used in traditional medicine, and furosemide, a drug commonly used to treat heart and kidney conditions. More specifically, the study aimed to understand how the presence of red ginseng might affect the concentration of furosemide in the bodies of horses.

Methodology

  • The research involved dividing the horses into two groups: those that consumed red ginseng together with furosemide (experimental group), and those that only received furosemide (control group).
  • The experimental group received 600 mg/kg/day of red ginseng every morning for three weeks, along with a single bolus of furosemide (0.5 mg/kg).
  • Blood samples were taken from all horses from 0 to 24 hours after the administration of furosemide. These samples were then analyzed using liquid chromatography, a method used for separating compounds in a mixture, coupled with tandem mass spectrometry, a process used to identify and quantify the compounds separated.

Results

  • Four ginsenosides — a type of natural product found in ginseng — were detected in the horse plasma. Of the four, Rb1 and Rc showed a high concentration distribution in the plasma.
  • In the experimental group (those who consumed both red ginseng and furosemide), a significant increase was observed in the concentration, area under the curve (AUC), and rate of furosemide absorption. In contrast, the clearance rate (CL), volume of distribution (V), and half-life (T) of the drug was decreased. This indicates that red ginseng might have some impact on the pharmacokinetics of furosemide.

Conclusion

The study suggests that red ginseng can alter the body’s handling of furosemide, making the latter more concentrated and available in the body while decreasing its clearance rate. The implications of these findings, however, require further studies to validate the clinical relevance of the red ginseng-furosemide interaction.

Cite This Article

APA
Kwak YB, Lee E, Choi H, Park T, Kim A, Kim J, Yoon J, Yoo HH. (2023). A pharmacokinetic study on red ginseng with furosemide in equine. Front Vet Sci, 10, 1319998. https://doi.org/10.3389/fvets.2023.1319998

Publication

Frontiers in veterinary science
ISSN: 2297-1769
NlmUniqueID: 101666658
Country: Switzerland
Language: English
Volume: 10
Pages: 1319998
PII: 1319998

Researcher Affiliations

Kwak, Young Beom
  • Racing Laboratory, Korea Racing Authority, Jeju-si, Jeju, Republic of Korea.
Lee, Eunkyu
  • Institute of Pharmaceutical Science and Technology and College of Pharmacy, Hanyang University, Ansan, Republic of Korea.
Choi, Hyunjoo
  • Training Support Team, Jeju Stud Farm, Korea Racing Authority, Jeju-si, Jeju, Republic of Korea.
Park, Taemook
  • Equine Clinic, Korea Racing Authority, Jeju-si, Jeju, Republic of Korea.
Kim, Ahram
  • Equine Clinic, Jeju Stud Farm, Korea Racing Authority, Jeju-si, Jeju, Republic of Korea.
Kim, Jungon
  • Management Team, Jeju Stud Farm, Korea Racing Authority, Jeju-si, Jeju, Republic of Korea.
Yoon, Jungho
  • Equine Clinic, Jeju Stud Farm, Korea Racing Authority, Jeju-si, Jeju, Republic of Korea.
Yoo, Hye Hyun
  • Institute of Pharmaceutical Science and Technology and College of Pharmacy, Hanyang University, Ansan, Republic of Korea.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

This article includes 46 references
  1. Vuksan V, Sung MK, Sievenpiper JL, Stavro PM, Jenkins AL, Di Buono M. Korean red ginseng (Panax Ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety.. Nutr Metab Cardiovasc Dis (2008) 18:46–56.
    doi: 10.1016/j.numecd.2006.04.003pubmed: 16860976google scholar: lookup
  2. Lee SM, Bae BS, Park HW, Ahn NG, Cho BG, Cho YL. Characterization of Korean red ginseng (Panax Ginseng Meyer): history, preparation method, and chemical composition.. J Ginseng Res (2015) 39:384–91.
    doi: 10.1016/j.jgr.2015.04.009pmc: PMC4593794pubmed: 26869832google scholar: lookup
  3. Yang WZ, Hu Y, Wu WY, Ye M, Guo DA. Saponins in the genus Panax L. (Araliaceae): a systematic review of their chemical diversity.. Phytochemistry (2014) 106:7–24.
    doi: 10.1016/j.phytochem.2014.07.012pubmed: 25108743google scholar: lookup
  4. Song C, Milliken T. The rhino horn trade in South Korea: still cause for concern.. Pachyderm (1993) 46:5–11.
  5. Jang DJ, Lee MS, Shin BC, Lee YC, Ernst E. Red ginseng for treating erectile dysfunction: a systematic review.. Br J Clin Pharmacol (2008) 66:444–50.
    doi: 10.1111/j.1365-2125.2008.03236.xpmc: PMC2561113pubmed: 18754850google scholar: lookup
  6. Ramesh T, Kim SW, Hwang SY, Sohn SH, Yoo SK, Kim SK. Panax Ginseng reduces oxidative stress and restores antioxidant capacity in aged rats.. Nutr Res (2012) 32:718–26.
    doi: 10.1016/j.nutres.2012.08.005pubmed: 23084645google scholar: lookup
  7. Wu W, Jiao C, Li H, Ma Y, Jiao L, Liu S. LC-MS based metabolic and Metabonomic studies of Panax Ginseng.. Phytochem Anal (2018) 29:331–40.
    doi: 10.1002/pca.2752pubmed: 29460310google scholar: lookup
  8. Becker BN, Greene J, Evanson J, Chidsey G, Stone WJ. Ginseng-induced diuretic resistance.. JAMA (1996) 276:606–7.
    doi: 10.1001/jama.1996.03540080028021pubmed: 8773630google scholar: lookup
  9. Jung J, Jang HJ, Eom SJ, Choi NS, Lee NK, Paik HD. Fermentation of red ginseng extract by the probiotic Lactobacillus Plantarum Kccm 11613p: Ginsenoside conversion and antioxidant effects.. J Ginseng Res (2019) 43:20–6.
    doi: 10.1016/j.jgr.2017.07.004pmc: PMC6323145pubmed: 30662290google scholar: lookup
  10. Jovanovski E, Jenkins A, Dias AG, Peeva V, Sievenpiper J, Arnason JT. Effects of Korean red ginseng (Panax Ginseng C.A. Mayer) and its isolated Ginsenosides and polysaccharides on arterial stiffness in healthy individuals.. Am J Hypertens (2010) 23:469–72.
    doi: 10.1038/ajh.2010.5pubmed: 20134405google scholar: lookup
  11. Hyun SH, Kim SW, Seo HW, Youn SH, Kyung JS, Lee YY. Physiological and pharmacological features of the non-Saponin components in Korean red ginseng.. J Ginseng Res (2020) 44:527–37.
    doi: 10.1016/j.jgr.2020.01.005pmc: PMC7322739pubmed: 32617032google scholar: lookup
  12. Liu H, Lu X, Hu Y, Fan X. Chemical constituents of Panax Ginseng and Panax Notoginseng explain why they differ in therapeutic efficacy.. Pharmacol Res (2020) 161:105263.
    doi: 10.1016/j.phrs.2020.105263pubmed: 33127555google scholar: lookup
  13. Ratan ZA, Haidere MF, Hong YH, Park SH, Lee JO, Lee J. Pharmacological potential of ginseng and its major component Ginsenosides.. J Ginseng Res (2021) 45:199–210.
    doi: 10.1016/j.jgr.2020.02.004pmc: PMC8020288pubmed: 33841000google scholar: lookup
  14. Wu W, Song F, Guo D, Mi J, Qin Q, Yu Q. Mass spectrometry-based approach in ginseng research: a promising way to metabolomics.. Curr Anal Chem (2012) 8:43–66.
    doi: 10.2174/157341112798472189google scholar: lookup
  15. Ponto LL, Schoenwald RD. Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (part II).. Clin Pharmacokinet (1990) 18:460–71.
    doi: 10.2165/00003088-199018060-00003pubmed: 2191821google scholar: lookup
  16. Oh SW, Han SY. Loop diuretics in clinical practice.. Electrolyte Blood Press (2015) 13:17–21.
    doi: 10.5049/EBP.2015.13.1.17pmc: PMC4520883pubmed: 26240596google scholar: lookup
  17. Kramer BK, Schweda F, Riegger GA. Diuretic treatment and diuretic resistance in heart failure.. Am J Med (1999) 106:90–6.
    doi: 10.1016/s0002-9343(98)00365-9pubmed: 10320123google scholar: lookup
  18. Hinchcliff KW, Morley PS, Guthrie AJ. Efficacy of furosemide for prevention of exercise-induced pulmonary hemorrhage in thoroughbred racehorses.. J Am Vet Med Assoc (2009) 235:76–82.
    doi: 10.2460/javma.235.1.76pubmed: 19566461google scholar: lookup
  19. Nordt SP, Williams SR, Manoguerra AS, Clark RF. Clarithromycin induced digoxin toxicity.. J Accid Emerg Med (1998) 15:194–5.
    doi: 10.1136/emj.15.3.194pmc: PMC1343067pubmed: 9639187google scholar: lookup
  20. Ho KM, Power BM. Benefits and risks of furosemide in acute kidney injury.. Anaesthesia (2010) 65:283–93.
    doi: 10.1111/j.1365-2044.2009.06228.xpubmed: 20085566google scholar: lookup
  21. Yeh ML, Chang YJ, Yeh SJ, Huang LJ, Yen YT, Wang PY. Potential drug-drug interactions in pediatric outpatient prescriptions for newborns and infants.. Comput Methods Prog Biomed (2014) 113:15–22.
    doi: 10.1016/j.cmpb.2013.07.016pubmed: 24209715google scholar: lookup
  22. Sardesai VM. Herbal medicines: poisons or potions?. J Lab Clin Med (2002) 139:343–8.
    doi: 10.1067/mlc.2002.124582pubmed: 12066132google scholar: lookup
  23. Coon JT, Ernst E. Panax Ginseng: a systematic review of adverse effects and drug interactions.. Drug Saf (2002) 25:323–44.
    doi: 10.2165/00002018-200225050-00003pubmed: 12020172google scholar: lookup
  24. Tarirai C, Viljoen AM, Hamman JH. Herb-drug pharmacokinetic interactions reviewed.. Expert Opin Drug Metab Toxicol (2010) 6:1515–38.
    doi: 10.1517/17425255.2010.529129pubmed: 21067427google scholar: lookup
  25. Food and Drug Administration. Bioanalytical method validation guidance for industry.. (2018).
  26. Pang Z, Chong J, Zhou G, de Lima Morais DA, Chang L, Barrette M. Metaboanalyst 5.0: narrowing the gap between raw spectra and functional insights.. Nucleic Acids Res (2021) 49:W388–96.
    doi: 10.1093/nar/gkab382pmc: PMC8265181pubmed: 34019663google scholar: lookup
  27. Xie HT, Wang GJ, Sun JG, Tucker I, Zhao XC, Xie YY. High performance liquid chromatographic–mass spectrometric determination of Ginsenoside Rg3 and its metabolites in rat plasma using solid-phase extraction for pharmacokinetic studies.. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 818:167–73.
    doi: 10.1016/j.jchromb.2004.12.028pubmed: 15734156google scholar: lookup
  28. Yang Y, Yang Y, Qiu H, Ju Z, Shi Y, Wang Z. Localization of constituents for determining the age and 2parts of ginseng through ultraperfomance liquid chromatography quadrupole/time of flight-mass spectrometry combined with desorption electrospray ionization mass spectrometry imaging.. J Pharm Biomed Anal (2021) 193:113722.
    doi: 10.1016/j.jpba.2020.113722pubmed: 33171337google scholar: lookup
  29. Choi MK, Jin S, Jeon JH, Kang WY, Seong SJ, Yoon YR. Tolerability and pharmacokinetics of Ginsenosides Rb1, Rb2, Rc, Rd, and compound K after single or multiple Administration of red Ginseng Extract in human beings.. J Ginseng Res (2020) 44:229–37.
    doi: 10.1016/j.jgr.2018.10.006pmc: PMC7031742pubmed: 32148404google scholar: lookup
  30. Huang X, Mees ED, Vos P, Hamza S, Braam B. Everything we always wanted to know about furosemide but were afraid to ask.. Am J Physiol Renal Physiol (2016) 310:F958–71.
    doi: 10.1152/ajprenal.00476.2015pubmed: 26911852google scholar: lookup
  31. Hasegawa M, Kusuhara H, Adachi M, Schuetz JD, Takeuchi K, Sugiyama Y. Multidrug resistance-associated protein 4 is involved in the urinary excretion of hydrochlorothiazide and furosemide.. J Am Soc Nephrol (2007) 18:37–45.
    doi: 10.1681/ASN.2005090966pubmed: 17135398google scholar: lookup
  32. Vallon V, Rieg T, Ahn SY, Wu W, Eraly SA, Nigam SK. Overlapping in vitro and in vivo specificities of the organic anion transporters Oat1 and Oat3 for loop and thiazide diuretics.. Am J Physiol Renal Physiol (2008) 294:F867–73.
    doi: 10.1152/ajprenal.00528.2007pubmed: 18216144google scholar: lookup
  33. Seong SJ, Kang WY, Heo JK, Jo J, Choi WG, Liu KH. A Comprehensive in Vivo and in vitro assessment of the drug interaction potential of red ginseng.. Clin Ther (2018) 40:1322–37.
    doi: 10.1016/j.clinthera.2018.06.017pubmed: 30078466google scholar: lookup
  34. Fang ZZ, Cao YF, Hu CM, Hong M, Sun XY, Ge GB. Structure-inhibition relationship of Ginsenosides towards Udp-glucuronosyltransferases (Ugts).. Toxicol Appl Pharmacol (2013) 267:149–54.
    doi: 10.1016/j.taap.2012.12.019pubmed: 23306165google scholar: lookup
  35. He YJ, Fang ZZ, Ge GB, Jiang P, Jin HZ, Zhang WD. The inhibitory effect of 20(S)-Protopanaxatriol (Ppt) towards Ugt1a1 and Ugt2b7.. Phytother Res (2013) 27:628–32.
    doi: 10.1002/ptr.4755pubmed: 22736593google scholar: lookup
  36. Ramanathan MR, Penzak SR. Pharmacokinetic drug interactions with Panax Ginseng.. Eur J Drug Metab Pharmacokinet (2017) 42:545–57.
    doi: 10.1007/s13318-016-0387-5pubmed: 27864798google scholar: lookup
  37. Jeon JH, Lee S, Lee W, Jin S, Kwon M, Shin CH. Herb–drug interaction of red ginseng extract and Ginsenoside Rc with valsartan in rats.. Molecules (2020) 25:622.
    doi: 10.3390/molecules25030622pmc: PMC7037682pubmed: 32023909google scholar: lookup
  38. Soma LR, Uboh CE. Review of furosemide in horse racing: its effects and regulation.. J Vet Pharmacol Ther (1998) 21:228–40.
    doi: 10.1046/j.1365-2885.1998.00132.xpubmed: 9673965google scholar: lookup
  39. Tan C, Xiao L, Chen W, Chen S. Germanium in ginseng is low and causes no sodium and water retention or renal toxicity in the diuretic-resistant rats.. Exp Biol Med (2015) 240:1505–12.
    doi: 10.1177/1535370215571874pmc: PMC4935308pubmed: 25711879google scholar: lookup
  40. Raspa F, Tarantola M, Muca E, Bergero D, Soglia D, Cavallini D. Does feeding management make a difference to behavioural activities and welfare of horses reared for meat production?. Animals (2022) 12:1740.
    doi: 10.3390/ani12141740pmc: PMC9311627pubmed: 35883287google scholar: lookup
  41. Raspa F, Vervuert I, Capucchio MT, Colombino E, Bergero D, Forte C. A high-starch vs. high-fibre diet: effects on the gut environment of the different intestinal compartments of the horse digestive tract.. BMC Vet Res (2022) 18:187.
    doi: 10.1186/s12917-022-03289-2pmc: PMC9118577pubmed: 35590319google scholar: lookup
  42. Elghandour MM, Reddy PRK, Salem AZ, Reddy PPR, Hyder I, Barbabosa-Pliego A. Plant bioactives and extracts as feed additives in horse nutrition.. J Equine Vet (2018) 69:66–77.
    doi: 10.1016/j.jevs.2018.06.004google scholar: lookup
  43. Pearson W, Omar S, Clarke AF. Low-dose ginseng (Panax Quinquefolium) modulates the course and magnitude of the antibody response to vaccination against equid herpesvirus 1 in horses.. Can J Vet Res (2007) 71:213–217.
    pmc: PMC1899868pubmed: 17695597
  44. Choi SH, Jung SW, Lee BH, Kim HJ, Hwang SH, Kim HK. Ginseng pharmacology: a new paradigm based on Gintonin-lysophosphatidic acid receptor interactions.. Front Pharmacol (2015) 6:245.
    doi: 10.3389/fphar.2015.00245pmc: PMC4621423pubmed: 26578955google scholar: lookup
  45. Shergis JL, Zhang AL, Zhou W, Xue CC. Panax Ginseng in randomised controlled trials: a systematic review.. Phytother Res (2013) 27:949–65.
    doi: 10.1002/ptr.4832pubmed: 22969004google scholar: lookup
  46. Hu Z, Yang X, Ho PCL, Chan SY, Heng PWS, Chan E. Herb-drug interactions: a literature review.. Drugs (2005) 65:1239–82.
    doi: 10.2165/00003495-200565090-00005pubmed: 15916450google scholar: lookup

Citations

This article has been cited 0 times.
Subscribe to our newsletter
Join 99,109 horse owners like you who receive our email updates on horse health and nutrition.